Blood administration

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

bentrider

Full Member
10+ Year Member
Joined
Apr 10, 2011
Messages
24
Reaction score
0
I am being told that I should follow blood bank rules including;
1. no medications through line while blood is infusing
2. only give blood with normal saline.

What do others think and anyone aware of studies showing above rules do not have to be followed during an anesthetic?
 
I am being told that I should follow blood bank rules including;
1. no medications through line while blood is infusing
2. only give blood with normal saline.

What do others think and anyone aware of studies showing above rules do not have to be followed during an anesthetic?

Who is doing the telling?
 
OR nurse reported CRNA to administration for not following blood bank policy...a sad state of affairs in my opinion.
 
If it's a nurse-to-nurse thing, I'm guessing your only alternative is to change the policy, or at least get a waiver for the OR.

I could be wrong, but I'm guessing your hospital's policy is written to comply with the AABB, which has one of the strictest set of guidelines.
 
Yes our institutional guidelines are based on AABB recommendations. I have been asked to justify administering each anesthetic medication through a blood line. Apparently there is literature to support administering most narcotics. I am reluctant to only use normal saline for massive blood transfusions sine it can cause hyperchloremic acidosis.
 
What do others think . . . .

The Circular of Information (basically the product insert for RBCs in the US) reads:

- No medications or solutions may be routinely added to or infused through the same tubing with blood or blood components with the exception of 0.9% Sodium Chloride, Injection (USP), unless 1) they have been approved for this use by the FDA or 2) there is documentation available to show that the addition is safe and does not adversely affect the blood or blood component.

- Lactated Ringer's, Injection (USP) or other solutions containing calcium should never be added to or infused through the same tubing with blood or blood components containing citrate.

http://www.aabb.org/resources/bct/Documents/coi0809r.pdf

I think that while you might be able to find studies that show that the addition doesn't have adverse effects on the patient, it's going to be very difficult to find studies that have specifically looked at adverse effects on the component (e.g. decreased efficacy, increased risk of side effects, and so on . . . .)

Just for fun, the Canadian Circular of Information for red cells reads:

No medications or solutions, with the exception of 0.9% sodium chloride injection, may be added to or infused through the same tubing with Red Blood Cells LR SAGM added. In particular, the addition of commonly used solutions such as D5W (5% dextrose in water) or additives such as calcium (e.g. in Lactated Ringers), should never be added to, or administered concurrently through the same vascular access as blood or blood components. Co-administration of ABO-compatible plasma or 5% albumin can be performed at the discretion of the recipient's physician.

http://blood.ca/centreapps/internet/uw_v502_mainengine.nsf/page/E_COI

Blood banking operates on the precautionary principle; all springs from this.
 
Last edited:
I am being told that I should follow blood bank rules including;
1. no medications through line while blood is infusing
2. only give blood with normal saline.

What do others think and anyone aware of studies showing above rules do not have to be followed during an anesthetic?

Those are nursing policies. 😀

I don't start an extra IV just for blood. Our PACU nurses in particular get pissed if we bring in a patient with blood running and only one IV. I tell them if they want another line, feel free, but it's not necessary from an anesthesia standpoint.

I don't mix anything with blood except saline BUT there's no reason in the world you can't piggyback it into a line that has LR and clamp off the LR while the blood is infusing.
 
The Circular of Information (basically the manufacturer's instructions for blood in the US), read:

- No medications or solutions may be routinely added to or infused through the same tubing with blood or blood components with the exception of 0.9% Sodium Chloride, Injection (USP), unless 1) they have been approved for this use by the FDA or 2) there is documentation available to show that the addition is safe and does not adversely affect the blood or blood component.

- Lactated Ringer's, Injection (USP) or other solutions containing calcium should never be added to or infused through the same tubing with blood or blood components containing citrate.

I think that while you might be able to find studies that show that the addition doesn't have adverse effects on the patient, it's going to be very difficult to find studies that have specifically looked at adverse effects on the component (e.g. decreased efficacy, increased risk of side effects, and so on . . . .)

BTW - most of us consider the lab to be the # 1 biggest PIA department in the hospital - FARRRRRRRR more interested in rules, policies, and procedures than actual patient care. You quoting rules from some manual simply proves my point.
 
not really a big deal for massive transfusion (re:NS) since you shouldnt be giving a lot of crystalloid anyway, and your blood should be going in alone or with plasma.
 
Oh no, not this BS again..


(For those of you who don't want to read the whole thing, the evidence suggests that LR and PRBCs are compatible as long as the ratio of LR to PRBCs does not exceed 1:1. A safety margin of 1:2 is probably a good idea)


In 1975, Ryden and Oberman published the first data on the Compatibility of Common Intravenous Solutions with CPD Blood. Working with CPD preserved whole blood, they demonstrated grossly visible clot formation in vitro in samples of LR and whole blood at a citrate: calcium ratio of 4:1 or lower when incubated for 5 minutes. Largely based on these findings, AABB incorporated the prohibition against the combination of LR and blood components when they developed their guidelines.

Then, in 1991, Cull and Lally looked at the Compatibility of (CPD preserved) packed erythrocytes and Ringer's lactate solution.. They examined a variety of ratios of CPD PRBCs: LR from 5:1 to 1:20. Clotting was observed in the 1:1 dilution, but not in the 2:1 or 5:1 dilutions at up to two hours. Units of PRBCs diluted with LR and passed through a 170 micron filter were compared to PRBCs similarly diluted with NS. No difference in flow rate was found.

In 1998, Lorenzo et al advised that blood bank guidelines be revised to allow the use of LR in the rapid transfusion of PRBCs when they assessed infusion time, filter weight, and clot formation after admixing whole blood and PRBCs with NS, LR, and LR with increasing concentrations of added calcium chloride from 1g to 5g. They found no differences except for the presence of visible clot in the LR + 5g calcium chloride mixture.

In 2009, Albert et al found that Ringer's lactate is compatible with the rapid infusion of AS-3 preserved packed red blood cells. when they used ELISA to compare prothrombin activation fragment 1 + 2 (the breakdown products of thrombin generation) levels in units of PRBCs similarly diluted in NS and LR then run through filters and fluid warmers (to simulate intraoperative transfusion practices) and found the levels of F1+2 to be sub-physiologic.

Then last year, Levac et al demonstrated that Ringer's lactate is compatible with saline-adenine-glucose-mannitol preserved packed red blood cells for rapid transfusion.. "Samples from 12 units of SAGM-PRBC were diluted from 0-97.5% with RL and normal saline (NS), incubated for 30 min, and passed through 40 μm filters." F1+2 levels were measured via ELISA. 8 samples were diluted with LR and incubated for 30 to 240 min and analyzed in a similar manner. At 120 minutes and up, some clotting was observed, but there was no clotting at 60 minutes. They concluded that LR/ PRBC co-administration is safe as long as cells are administered over 60 minutes or less.



Though generally resulting in benign hemoglobinemia and hemoglobinuria, there are case reports of serious sequelae from acute non-immune hemolytic transfusion reaction (pseudo-hemolytic transfusion reaction) including renal failure and hypotension. However, lysis of cells was never the concern with LR. It is an accurate concern if red blood cells are diluted/ co-administered in hypotonic solutions like D5W which should never be done.


To my knowledge, there are no papers refuting the safety of PRBC/LR co-administration with modern anticoagulant techniques. If you know of any, please share.

I am not aware of any study of the effect of LR other factors, although platelet activation might occur. That would be an interesting thing to look at.

Personally, I still make a good-faith effort to dilute/ transfuse with NS because the guidelines exist and have not been update to reflect the data (the number one problem with guidelines IMHO). However, I don't go out of my way if there is LR hanging and I need to give products rapidly. I do always run platelets through their own line so the latter is essentially a null issue to me.

- pod

Blood with LR is okay as long as you don't exceed 1:1. It is probably a good idea to keep a safety margin and not exceed 1:2 LR to PRBC ratio.

And I am certain that your blood bank would be aghast at the rate at which we run in blood products. I once had a path resident observing me during a cardiac case. She thought the patient might be having a adverse reaction to a component (we were really just seeing the typical myocardial depression from rapid FFP admin). She wanted me to pull the component for testing. I held up the eight bags of various product that had run in over the previous 5 minutes and asked her which one. The look on her face was priceless.

- pod
 
I think that while you might be able to find studies that show that the addition doesn't have adverse effects on the patient, it's going to be very difficult to find studies that have specifically looked at adverse effects on the component (e.g. decreased efficacy, increased risk of side effects, and so on . . . .)

Really? Are we treating a patient or are we treating the blood products? "Oh thank goodness, we finally found a host for this bag of PRBCs! I thought it would never happen!"
 
Top